An interventional study of Hypnosis in Dermatitis, sponsored by Centre Hospitalier Universitaire de la Réunion. Active, not recruiting at 1 site in Reunion. Open to participants aged 8 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-09-24.
Sponsored by Centre Hospitalier Universitaire de la Réunion · Not applicable, Interventional, and Supportive care
Atopic dermatitis (AD) is a chronic inflammatory dermatosis, common in children. It causes pruritus and skin lesions that can have a significant impact on patients' quality of life. AD can be difficult to treat because of its chronicity, demanding local care, corticophobia and the financial cost of non-reimbursed products. Patients are often looking for therapeutic alternatives. Medical hypnosis is a therapeutic alternative via hypnoanalgesia induced by direct suggestions of comfort and skin soothing and via anxiolysis, by working on stress management and self-esteem reinforcement. Four studies are interested in its action in AD and seem to show a reduction in pruritus, skin pain, an improvement in the intensity of atopic dermatitis, sleep, mood and for some a cure of AD. These results are encouraging but limited by the absence of a control group or by the small population included. Therefore, we propose in a first step to evaluate the feasibility of an hypnosis program through a pilot study, designed in the miniature format of a future, larger scale, randomized controlled trial.
238 studies on the registry are indexed under Dermatitis; 34 are open to participants now.
This study's planned enrollment of 32 is below the median of 68 across 191 interventional studies indexed under Dermatitis.
Browse Dermatitis studies →Centre Hospitalier Universitaire de la Réunion is the lead sponsor of 141 studies on the registry; 37 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Behavioral: Hypnosis
The experimental group will receive 2 standardized hypnosis sessions via the "superhero costume" technique performed during this collective therapeutic education program, completed by a reinforcement through the practice of self-hypnosis at home guided by the listening of an audio recording
Asses the patient recruitment rate
The recruitment rate is the proportion of patients recruited into the pilot study: number of patients included/number of patients to whom the study was proposed.
Time frame: 24 months
Assess patient compliance with self-hypnosis practice
Assess patients' adherence to self-hypnosis practice at home, on a self-reported basis, using an adherence log in the experimental arm by: * The adherence rate at M1 * The variation in the adherence rate over time
Time frame: At 1 month, 3 months, and 6 months after inclusion
Patient lost sight of
Evaluate the rate of patient who has been lost sight of(M1, M3, M6) in both arms, measured by the proportion of patients lost sight of/number of patients included at baseline
Time frame: At 1 month, 3 months, and 6 months after inclusion
Patient satisfaction
Assess patient satisfaction with the hypnosis program in the experimental arm using a satisfaction questionnaire
Time frame: At 1 month, 3 months, and 6 months after inclusion
Improvements to the hypnosis program
Describe possible improvements to the hypnosis program in the experimental arm at M6 through focus group interviews with a group of volunteers aged 8-11 and a group of volunteers aged 12-17.
Time frame: At 6 months after inclusion
Effectiveness
Evaluate the effectiveness of a hypnosis program (exploratory) * On the control of atopic dermatitis ( The change in the mean AD control score, measured by the ADCT) * On the severity of atopic dermatitis (The change in the mean AD severity score, measured by the PO-SCORAD)
Time frame: At 1 month, 3 months, and 6 months after inclusion
Parents' overall impression
Assess parents' overall impression of their child's AD progress with the hypnosis program, via a questionnaire
Time frame: At 1 month, 3 months, and 6 months after enrollment
Plan to share: No
Started Aug 2024 (actual). Primary completion is estimated for Feb 2027, 30 months after the start.
Of 36 interventional studies with no phase under Dermatitis, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 13. This study's planned 30 months is above that.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire de la Réunion →